SE7500130L - - Google Patents

Info

Publication number
SE7500130L
SE7500130L SE7500130A SE7500130A SE7500130L SE 7500130 L SE7500130 L SE 7500130L SE 7500130 A SE7500130 A SE 7500130A SE 7500130 A SE7500130 A SE 7500130A SE 7500130 L SE7500130 L SE 7500130L
Authority
SE
Sweden
Prior art keywords
influenza
components
virus
type
cationic detergent
Prior art date
Application number
SE7500130A
Other languages
Unknown language ( )
English (en)
Other versions
SE427238B (sv
Inventor
H Bachmayer
G Schmidth
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE7500130L publication Critical patent/SE7500130L/
Publication of SE427238B publication Critical patent/SE427238B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16211Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
SE7500130A 1974-01-14 1975-01-07 Sett att isolera influensavirus-subenheter SE427238B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (US20100154141A1-20100624-C00001.png) 1974-01-14 1974-01-14

Publications (2)

Publication Number Publication Date
SE7500130L true SE7500130L (US20100154141A1-20100624-C00001.png) 1975-07-15
SE427238B SE427238B (sv) 1983-03-21

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7500130A SE427238B (sv) 1974-01-14 1975-01-07 Sett att isolera influensavirus-subenheter

Country Status (27)

Country Link
JP (2) JPS58407B2 (US20100154141A1-20100624-C00001.png)
AT (1) AT345449B (US20100154141A1-20100624-C00001.png)
AU (1) AU500250B2 (US20100154141A1-20100624-C00001.png)
BE (1) BE824372A (US20100154141A1-20100624-C00001.png)
CA (1) CA1049406A (US20100154141A1-20100624-C00001.png)
CH (1) CH589453A5 (US20100154141A1-20100624-C00001.png)
CS (1) CS191254B2 (US20100154141A1-20100624-C00001.png)
DD (1) DD116239A5 (US20100154141A1-20100624-C00001.png)
DE (1) DE2500785B2 (US20100154141A1-20100624-C00001.png)
DK (1) DK140003B (US20100154141A1-20100624-C00001.png)
ES (1) ES433759A1 (US20100154141A1-20100624-C00001.png)
FI (1) FI54053C (US20100154141A1-20100624-C00001.png)
FR (1) FR2257305B1 (US20100154141A1-20100624-C00001.png)
GB (1) GB1498261A (US20100154141A1-20100624-C00001.png)
HK (1) HK56380A (US20100154141A1-20100624-C00001.png)
HU (1) HU173920B (US20100154141A1-20100624-C00001.png)
IE (1) IE40794B1 (US20100154141A1-20100624-C00001.png)
IL (1) IL46426A (US20100154141A1-20100624-C00001.png)
MY (1) MY8100204A (US20100154141A1-20100624-C00001.png)
NL (1) NL166622C (US20100154141A1-20100624-C00001.png)
NO (1) NO143128C (US20100154141A1-20100624-C00001.png)
PH (1) PH14458A (US20100154141A1-20100624-C00001.png)
PL (1) PL93689B1 (US20100154141A1-20100624-C00001.png)
SE (1) SE427238B (US20100154141A1-20100624-C00001.png)
SU (1) SU616997A3 (US20100154141A1-20100624-C00001.png)
YU (1) YU41289B (US20100154141A1-20100624-C00001.png)
ZA (1) ZA75259B (US20100154141A1-20100624-C00001.png)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
AU2006310171B2 (en) * 2005-11-01 2011-02-17 Seqirus UK Limited Cell-derived viral vaccines with low levels of residual cell DNA by beta-propiolactone treatment
RU2496519C2 (ru) 2007-08-28 2013-10-27 Бакстер Интернэшнл Инк. Способ получения препарата, содержащего вирусные антигены, и применение препарата
JP6373376B2 (ja) 2013-11-15 2018-08-15 ノバルティス アーゲー 残留細胞培養不純物の除去

Also Published As

Publication number Publication date
DK140003C (US20100154141A1-20100624-C00001.png) 1979-10-29
MY8100204A (en) 1981-12-31
HU173920B (hu) 1979-09-28
GB1498261A (en) 1978-01-18
IL46426A0 (en) 1975-04-25
DK1475A (US20100154141A1-20100624-C00001.png) 1975-09-01
FR2257305A1 (US20100154141A1-20100624-C00001.png) 1975-08-08
FI54053B (fi) 1978-06-30
DE2500785A1 (de) 1975-07-31
DK140003B (da) 1979-06-05
NL166622C (nl) 1981-09-15
AT345449B (de) 1978-09-11
ATA21475A (de) 1978-01-15
IE40794B1 (en) 1979-08-15
CH589453A5 (US20100154141A1-20100624-C00001.png) 1977-07-15
CS191254B2 (en) 1979-06-29
YU41289B (en) 1987-02-28
AU7730575A (en) 1976-07-15
PL93689B1 (US20100154141A1-20100624-C00001.png) 1977-06-30
SU616997A3 (ru) 1978-07-25
NO143128B (no) 1980-09-15
AU500250B2 (en) 1979-05-17
PH14458A (en) 1981-07-29
DD116239A5 (US20100154141A1-20100624-C00001.png) 1975-11-12
JPS50100224A (US20100154141A1-20100624-C00001.png) 1975-08-08
NL7500301A (nl) 1975-07-16
FI54053C (fi) 1978-10-10
CA1049406A (en) 1979-02-27
DE2500785C3 (US20100154141A1-20100624-C00001.png) 1980-09-11
HK56380A (en) 1980-10-16
ES433759A1 (es) 1977-02-16
JPS58407B2 (ja) 1983-01-06
DE2500785B2 (de) 1980-01-03
NL166622B (nl) 1981-04-15
YU5875A (en) 1984-04-30
IL46426A (en) 1978-01-31
JPS56127319A (en) 1981-10-06
NO143128C (no) 1980-12-29
ZA75259B (en) 1976-08-25
BE824372A (fr) 1975-07-14
NO750031L (US20100154141A1-20100624-C00001.png) 1975-08-11
JPS6035326B2 (ja) 1985-08-14
FR2257305B1 (US20100154141A1-20100624-C00001.png) 1982-03-19
SE427238B (sv) 1983-03-21
FI750014A (US20100154141A1-20100624-C00001.png) 1975-07-15
IE40794L (en) 1975-07-14

Similar Documents

Publication Publication Date Title
AU2684792A (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
BR9106374A (pt) Vacina oral e processo de extrair uma imunoresponsta em um mamifero
SE7500130L (US20100154141A1-20100624-C00001.png)
KR850001700A (ko) 단순 헤르페스 바이러스 서브유니트 왁진(Herpes Simplex Virus Subuait Vaccine)의 제조방법
US3674864A (en) Process for stabilizing preparations of interfering viruses
Bang Filamentous forms of Newcastle virus
Russell et al. Cell cooperation in antibody responses to influenza virus. I. Priming of helper T cells by internal components of the virion
ES8104405A1 (es) Procedimiento para preparar una vacuna de virus de gripe
GB1292803A (en) Improvements relating to the production of antigens
ES471615A1 (es) Procedimiento para aislar los componentes de glicoproteina de paramixovirus
ES430415A1 (es) Un procedimiento para preparar una vacuna de virus de la gripe atenuado.
Russell et al. Mumps Viral Cytolysin: I. Action on Human Epithelial Cells in Tissue Culture
GB1256457A (en) Diethylaminoethyldextran (deae-d) as adjuvant for vaccines for active immunisation
AU5573196A (en) A pluripotent vaccine against enveloped viruses
GB953992A (en) Vaccine products and method of preparing same
GB928807A (en) Combined poliomyelitis-diphtheria-tetanus-pertussis antigen and methods for its manufacture
GB1016586A (en) Vaccine for immunization of dogs against distemper and hepatitis contagiosa canis
GB1327870A (en) Process for the manufacture of a vaccine against infectious bursitis of chickens
Greer et al. Electron microscope study of the interaction of vaccinia virus with macrophages from immunized and nonimmunized rabbits
ES350690A1 (es) Un metodo para la concentracion y purificacion de los virusdel grupo de la influenza.
GB777018A (en) Poliomyelitis vaccine products and methods for preparing the same
Coggins et al. Serological Comparison with Rabbit Antisera of Hog Cholera Virus and Bovine Virus Diarrhea Virus.
GB1413401A (en) Influenza vaccine
PT100460A (pt) Partiiculas derivadas de virus de herpes e vacinas que as contem
郭元吉 et al. Influenza C virus isolated from pigs in China

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7500130-5

Effective date: 19940810

Format of ref document f/p: F